Karim Helmy

Karim Helmy is an accomplished professional with extensive experience in private investments and healthcare. Currently serving at Viking Global Investors since 2020, Karim has previously held significant roles including Vice President at Venrock (2017-2019) and Board Member at Corvidia Therapeutics (2018-2019). Prior to these positions, Karim worked as an Engagement Manager at McKinsey & Company (2014-2017) and completed an Internal Medicine Residency at Columbia University Medical Center (2013-2014). Academic credentials include a PhD from Memorial Sloan-Kettering Cancer Center (2008-2011) and early research experience at Genentech (2002-2006) and Maxygen (2000). Karim holds a Bachelor of Science in Biology from Stanford University and an MD/PhD from the University of Medicine and Dentistry of New Jersey.